[1]Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature, 1981, 292(5819): 154?156.
[2]Buehr M, Meek S, Blair K, Yang J, Ure J, Silva J, McLay R, Hall J, Ying QL, Smith A. Capture of authentic embryonic stem cells from rat blastocysts. Cell, 2008, 135(7): 1287?1298.
[3]Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science, 1998, 282(5391): 1145?1147.
[4]Suemori H, Tada T, Torii R, Hosoi Y, Kobayashi K, Imahie H, Kondo Y, Iritani A, Nakatsuji N. Establishment of embryonic stem cell lines from cynomolgus monkey blas?tocysts produced by ivf or icsi. Dev Dyn, 2001, 222(2): 273?279.
[5]Thomson JA, Kalishman J, Golos TG, Durning M, Harris CP, Hearn JP. Pluripotent cell lines derived from common marmoset (callithrix jacchus) blastocysts. Biol Reprod, 1996, 55(2): 254?259.
[6]Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cul?tures by defined factors. Cell, 2006, 126(4): 663?676.
[7]Robinton DA, Daley GQ. The promise of induced pluripotent stem cells in research and therapy. Nature, 2012, 481(7381): 295?305.
[8]Urano F. Wolfram syndrome ips cells: The first human cell model of endoplasmic reticulum disease. Diabetes, 2014, 63(3): 844?846.
[9] Phillips MJ, Perez ET, Martin JM, Reshel ST, Wallace KA, Capowski EE, Singh R, Wright LS, Clark EM, Barney PM, Stewart R, Dickerson SJ, Miller MJ, Percin EF, Thomson JA, Gamm DM. Modeling human retinal development with patient-specific Induced Pluripotent Stem cells rev?eals multiple roles for Visual System Homeobox 2. Stem Cells, 2014, 32(6): 1480–1492.
[10]Bock C, Kiskinis E, Verstappen G, Gu HC, Boulting G, Smith ZD, Ziller M, Croft GF, Amoroso MW, Oakley DH, Gnirke A, Eggan K, Meissner A. Reference maps of human es and ips cell variation enable high-throug?hput character?ization of pluripotent cell lines. Cell, 2011, 144(3): 439?452
[11]Shao KF, Koch C, Gupta MK, Lin Q, Lenz M, Laufs S, Denecke B, Schmidt M, Linke M, Hennies HC, Hescheler J, Zenke M, Zechner U, ?aric T, Wagner W. Induced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profiles. Mol Ther Jan, 2013, 21(1): 240–250.
[12]Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R, Lynch C, Harness JV, Lee S, Barrero MJ, Ku S, Martynova M, Semechkin R, Galat V, Gottesfeld J, Izpisua Belmonte JCI, Murry C, Keirstead HS, Park HS, Schmidt U, Laslett AL, Muller FJ, Nievergelt CM, Shamir R, Loring JF. Dynamic changes in the copy number of plu?ripotency and cell proliferation genes in human escs and ipscs during reprogramming and time in culture. Cell Stem Cell, 2011, 8(1): 106?118.
[13]Bar-Nur O, Russ HA, Efrat S, Benvenisty N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pan?creatic islet beta cells. Cell Stem Cell, 2011, 9(1): 17?23.
[14]Urbach A, Bar-Nur O, Daley GQ, Benvenisty N. Diffe?rential modeling of fragile x syndrome by human embr?yonic stem cells and induced pluripotent stem cells. Cell Stem Cell, 2010, 6(5): 407?411.
[15]Bao L, He LXZ, Chen JJ, Wu Z, Liao J, Rao LJ, Ren JT, Li H, Zhu H, Qian L, Gu YJ, Dai HM, Xu X, Zhou JQ, Wang W, Cui C, Xiao L. Reprogramming of ovine adult fibroblasts to pluripotency via drug-inducible expression of defined factors. Cell Res, 2011, 21(4): 600?608.
[16]Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ. Highly efficient reprogramming to pluripotency and dir?ected differentiation of human cells with synthetic mod?ified mrna. Cell Stem Cell, 2010, 7(5): 618?630.
[17]Hou P, Li Y, Zhang X, Liu C, Guan J, Li H, Zhao T, Ye J, Yang W, Liu K, Ge J, Xu J, Zhang Q, Zhao Y, Deng H. Pluripotent stem cells induce
